Paul Peter Tak

Insider Reports History

Entity
Individual
Location
Candel Therapeutics, Inc., 117 Kendrick St Suite 450, Needham, MA
Signature
/s/ Charles Schoch, as Attorney-in-Fact for Paul Peter Tak
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Peter Tak:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Executive Officer, Director Common Stock 295K $1.34M $4.56 Nov 29, 2024 Direct
Candel Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 1.76M Nov 21, 2024 Direct

Insider Reports Filed by Paul Peter Tak

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Nov 29, 2024 1 -$223K 4 Dec 3, 2024 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Nov 21, 2024 2 $20K 4 Nov 21, 2024 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Jul 17, 2024 1 -$146K 4 Jul 19, 2024 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Jul 11, 2024 1 -$121K 4 Jul 15, 2024 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Nov 28, 2023 1 -$39.1K 4 Nov 30, 2023 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Nov 26, 2023 1 $0 4 Nov 28, 2023 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Apr 28, 2023 1 $0 4 May 2, 2023 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Dec 8, 2022 2 $30K 4 Dec 12, 2022 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Nov 28, 2022 1 $0 4 Nov 30, 2022 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Feb 28, 2022 1 $0 4 Mar 1, 2022 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Jul 29, 2021 1 $200K 4 Aug 2, 2021 Chief Executive Officer, Director
CADL Candel Therapeutics, Inc. Jul 26, 2021 0 $0 3 Jul 26, 2021 President & CEO, Director